Lv6
2325 积分 2022-06-06 加入
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
2天前
已完结
HB0025 With Chemotherapy for Advanced Non–Small Cell Lung Cancer A Phase 2 Nonrandomized Clinical Trial
10天前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
24天前
已完结
A phase I, first-in-human dose-escalation and triple-negative breast cancer dose-expansion study of a TROP2-ADC F0024 (FDA018)
24天前
已完结
Beyond Zolbetuximab: Next-Generation Targeting Strategies for CLDN18.2
1个月前
已完结
生物制剂治疗慢性鼻窦炎伴鼻息肉专家共识(2025)
1个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
1个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
1个月前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial
1个月前
已完结